Join the Shingrix group to help and get support from people like you.
Shingrix News
Shingles Vaccine, Shingrix, Might Protect Against Heart Attack, Stroke
FRIDAY, Aug. 29, 2025 — The shingles vaccine not only protects against the painful skin infection, but also might provide heart health benefits, a new study says. Shingles vaccination also appears to ...
US FDA Approves GSK’s Shingrix in a Prefilled Syringe Presentation
London, UK 17 July 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster ...
Zoster Vaccine Has Dementia-Preventing or Delaying Effect
THURSDAY, April 3, 2025 – Zoster vaccination seems to have a dementia-preventing or dementia-delaying effect, according to a study published online April 2 in Nature. Markus Eyting, Ph.D., from...
Shingles Vaccine Protects Against Dementia
TUESDAY, April 2, 2025 – The shingles vaccine can do more than protect seniors from painful, blistering rashes. It also appears to protect older folks from dementia, researchers say. Seniors who got...
Everything You Need to Know About Shingles & the Shingles Vaccine
SUNDAY, Dec. 8, 2024 – Shingles can strike anyone who had chickenpox when they were young, and the intense pain that can accompany this body rash has sidelined many a senior. Here, one expert...
Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults
Philadelphia, London – 26 July 2021 – GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...
FDA Medwatch Alert: FDA Requires a Warning about Guillain-Barré Syndrome (GBS) be Included in the Prescribing Information for Shingrix
March 24, 2021 – FDA Safety Communication Purpose: To inform the public and healthcare providers that FDA has required and approved safety labeling changes to the Prescribing Information for...
CureVac’s Coronavirus Vaccine at the Center of a Fight for Control
CureVac, a German biopharmaceutical company, has hit the headlines after US President Trump tried to secure exclusive rights to its developmental coronavirus vaccine. The vaccine is being developed...
Shingrix (zoster vaccine recombinant, adjuvanted) Approved in the U.S. for Prevention of Shingles
London UK 20 October 2017 – GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the...